Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many covid-19 vaccine doses will be available for booster jabs to be given in September and October 2021.

The Government has confirmed we are preparing for a booster programme to take place later this year. We have secured early access to 397 million vaccines doses through supply agreements with six separate vaccine developers, of which four have been approved for use and three are currently in deployment. This includes agreements with:

• Pfizer/BioNTech for 100 million doses
• University of Oxford/AstraZeneca for 100 million doses
• Moderna for 17 million doses
• Novavax for 60 million doses
• Janssen for 20 million doses
• Valneva for 100 million doses

In addition, the Government has a reservation agreement with GlaxoSmithKline/Sanofi Pasteur for 60 million doses and a non-binding agreement with CureVac for 50 million doses.

Final decisions on what a booster programme would look like – including which vaccines will be used - will depend on the data from ongoing clinical trials, such as the COV-Boost trial, and advice from the independent medical experts at the Joint Committee on Vaccination and Immunisation (JCVI).